US FDA Panel To Consider Compounding Ban For Makena’s Active Ingredient

 
• By Sue Sutter
  
Hydroxyprogesterone caproate molecule
Hydroxyprogesterone caproate may be headed for a compounding ban. • Source: Shutterstock

More from Review Pathways

More from Pathways & Standards